Cross-Sector entity
Of the tracked stories, 2 of 2 also mention Adage Capital Partners GP L.L.C., the most common co-covered peer. market-trends accounts for 1 of the 2 tracked stories, while 1 other category carries the remainder. Each carries 2 original sources on average.
2 verified stories tracked
Last mentioned: Aug 13, 2026
Entity pulse
Figures are computed live from our source-verified story record — see our methodology for how impact and sentiment are derived.
Of the tracked stories, 2 of 2 also mention Adage Capital Partners GP L.L.C., the most common co-covered peer. market-trends accounts for 1 of the 2 tracked stories, while 1 other category carries the remainder. Each carries 2 original sources on average. We currently track 2 Cross-Sector stories that mention Focus Universal, Inc., all published on August 13, 2026.
Computed from the 2 stories linked to this entity. Beat comparisons are omitted because no baseline was available for this window.
Coverage cohort
Other entities that clear the same relevance threshold in stories also covering Focus Universal, Inc.. Shared-story counts are live from our verified record — not editorial picks.
Ensysce Biosciences short interest soared 619.9% to 364,278 shares as its stock trades at $0.30, while Focus Universal posted just $0.05M in quarterly revenue. The data highlights severe financial fragility across two small healthcare and device innovators.
SCYNEXIS shorts collapsed 87.6% to 320,181 shares, signaling bear exhaustion, while Ensysce Biosciences short interest exploded 619.9% to 364,278. Focus Universal also saw a 282.8% build, reflecting a stark divergence in microcap biotech sentiment.
Source: tickerreport.com · dailypolitical.com
